146 related articles for article (PubMed ID: 33448714)
1. Oral Contraceptive Use in Obese Adolescents: A Cautionary Tale.
Warad DM; Chattha AJ; Rodriguez V
J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1124-e1127. PubMed ID: 33448714
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Dinger J; Assmann A; Möhner S; Minh TD
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
[TBL] [Abstract][Full Text] [Related]
3. Hormonal contraception and venous thromboembolism.
Lidegaard Ø; Milsom I; Geirsson RT; Skjeldestad FE
Acta Obstet Gynecol Scand; 2012 Jul; 91(7):769-78. PubMed ID: 22568831
[TBL] [Abstract][Full Text] [Related]
4. Combined hormonal contraception and venous thromboembolism.
Martínez F; Avecilla A
Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
[TBL] [Abstract][Full Text] [Related]
5. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review.
Horton LG; Simmons KB; Curtis KM
Contraception; 2016 Dec; 94(6):590-604. PubMed ID: 27263039
[TBL] [Abstract][Full Text] [Related]
6. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic risks of oral contraceptives.
Rott H
Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
[TBL] [Abstract][Full Text] [Related]
8. Risk of venous thromboembolism in women taking the combined oral contraceptive: A systematic review and meta-analysis.
Bateson D; Butcher BE; Donovan C; Farrell L; Kovacs G; Mezzini T; Raynes-Greenow C; Pecoraro G; Read C; Baber R
Aust Fam Physician; 2016; 45(1):59-64. PubMed ID: 27051991
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use.
Dulicek P; Ivanova E; Kostal M; Sadilek P; Beranek M; Zak P; Hirmerova J
Clin Appl Thromb Hemost; 2018 Jul; 24(5):797-802. PubMed ID: 28884608
[TBL] [Abstract][Full Text] [Related]
10. Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data.
Schink T; Princk C; Braitmaier M; Haug U
BJOG; 2022 Dec; 129(13):2107-2116. PubMed ID: 35876787
[TBL] [Abstract][Full Text] [Related]
11. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N; Smith KP
Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
[TBL] [Abstract][Full Text] [Related]
12. The incidence and prognosis of thromboembolism associated with oral contraceptives: Age-dependent difference in Japanese population.
Sugiura K; Ojima T; Urano T; Kobayashi T
J Obstet Gynaecol Res; 2018 Sep; 44(9):1766-1772. PubMed ID: 29998477
[TBL] [Abstract][Full Text] [Related]
13. Contraception-related venous thromboembolism in adolescents.
O'Brien SH
Semin Thromb Hemost; 2014 Feb; 40(1):66-71. PubMed ID: 24356931
[TBL] [Abstract][Full Text] [Related]
14. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis.
van Vlijmen EF; Wiewel-Verschueren S; Monster TB; Meijer K
J Thromb Haemost; 2016 Jul; 14(7):1393-403. PubMed ID: 27121914
[TBL] [Abstract][Full Text] [Related]
15. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception.
Dragoman MV; Tepper NK; Fu R; Curtis KM; Chou R; Gaffield ME
Int J Gynaecol Obstet; 2018 Jun; 141(3):287-294. PubMed ID: 29388678
[TBL] [Abstract][Full Text] [Related]
16. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.
Reid R;
J Obstet Gynaecol Can; 2010 Dec; 32(12):1192-1197. PubMed ID: 21176332
[TBL] [Abstract][Full Text] [Related]
17. Birth Control Pills and Thrombotic Risks: Differences of Contraception Methods with and without Estrogen.
Rott H
Hamostaseologie; 2019 Feb; 39(1):42-48. PubMed ID: 30669160
[TBL] [Abstract][Full Text] [Related]
18. Risks of thromboembolism associated with hormonal contraceptives related to body mass index and aging in Japanese women.
Sugiura K; Kobayashi T; Ojima T
Thromb Res; 2016 Jan; 137():11-16. PubMed ID: 26672897
[TBL] [Abstract][Full Text] [Related]
19. Association of Risk for Venous Thromboembolism With Use of Low-Dose Extended- and Continuous-Cycle Combined Oral Contraceptives: A Safety Study Using the Sentinel Distributed Database.
Li J; Panucci G; Moeny D; Liu W; Maro JC; Toh S; Huang TY
JAMA Intern Med; 2018 Nov; 178(11):1482-1488. PubMed ID: 30285041
[TBL] [Abstract][Full Text] [Related]
20. A Review of Hormonal Contraception and Venous Thromboembolism in Adolescents.
Woods GM; Kerlin BA; O'Brien SH; Bonny AE
J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):402-408. PubMed ID: 27491960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]